The British Journal of Psychiatry · 1996 · 17 citations · 8 references
PharmacyPharmacotherapyPsychiatryChild PsychiatryPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyPsychopharmacology In ChildrenSchizophrenia PharmacotherapyTreatment Of Mental DisordersTreatment-resistant Psychiatric DisordersAntipsychotic Medication UseAntipsychotic-induced Tardive DyskinesiaChildhood SchizophreniaMental Health LegislationParental ConsentParental Informed ConsentPediatric Antipsychotic UseTardive Dyskinesia Treatment
BACKGROUND: Schizophrenia can be diagnosed in adults and requires treatment with antipsychotic medication. Clozapine is used effectively in adults with treatment-resistant schizophrenia but little is published on the use of clozapine in children. METHOD: Supported by parental consent and a second opinion, standardised observations were used to chart the progress of treatment with clozapine in a child in-patient detained under mental health legislation with severe drug-resistant schizophrenia and tardive dyskinesia. RESULTS: Sixteen months of clozapine treatment led to significant reduction of symptomatology with marked improvement in social functioning and diminished tardive dyskinesia. CONCLUSIONS: This case illustrates the successful use of clozapine in treatment-resistant childhood schizophrenia.
8
Clozapine for the Treatment-Resistant Schizophrenic
John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations
Medicine, Pharmacology, Psychiatry +16
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
G. M. Simpson, M. B., GH. B. et al. · Acta Psychiatrica Scandinavica · 1970 · 3.3K citations
Medicine, Pharmacology, Psychiatry +10
A Rating Scale for Drug-Induced Akathisia
Thomas R. E. Barnes · The British Journal of Psychiatry · 1989 · 2.2K citations
Medicine, Psychiatry, Psychology +17
Anchoring the BPRS: an aid to improved reliability.
Woerner Mg, Salvatore Mannuzza, Kane Jm · PubMed · 1988 · 333 citations